NCT03660904

Brief Summary

This study was conducted to evaluate and compare cryo-survival, re-expansion, and implantation rates of Day 5/6 human blastocysts that were vitrified with home-made media (HM) according to (Shady grove protocol) and warmed with gradual Thawing HM according to (Kuwayama protocol)with Global Fast Freeze/Thaw Kits (LifeGlobal, Canada).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
Last Updated

September 7, 2018

Status Verified

September 1, 2018

Enrollment Period

2 years

First QC Date

September 2, 2018

Last Update Submit

September 6, 2018

Conditions

Keywords

vitrificationblastocystshome-made media

Outcome Measures

Primary Outcomes (1)

  • blastocyst immediate survival

    The effect of Vitrification protocol on the blastocyst immediate survival

    0 hour at time of thawing

Secondary Outcomes (3)

  • pregnancy rate

    2 weeks after transfer

  • live birth rate

    9 months

  • Blastocyst survival at 6 hours

    6 hours after thawing

Study Arms (2)

Home made media

EXPERIMENTAL

home made vitrification \& thawing kit

Biological: home made vitrification & thawing kit

Commercial media

ACTIVE COMPARATOR

commercially available vitrification \& thawing kit

Biological: commercially made vitrification & thawing kit

Interventions

home made vitrification was made and prepared for vitrification of blastocysts then thawing with a prepared thawed media too

Home made media

commercially available vitrification \& thawing kit were made and prepared for vitrification of blastocysts then thawing with a prepared thawed media too

Commercial media

Eligibility Criteria

Age22 Years - 37 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsblastocysts of infertile couples
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age of the patients 22-37
  • All vitrified \& thawed blastocyst.
  • unexplained cases or ovarian factors for infertility.

You may not qualify if:

  • extremes of age
  • cases of uterine factor
  • endometriosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Embryo Loss

Condition Hierarchy (Ancestors)

Abortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
only the investigator knew the procedure and the media provided for each case
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Group 1 blastocysts were vitrified with the Vit (home made) HM according to shady grove protocol using open system on cryotop vit. device and thawed with gradual thawing technique using HM thawing media according to Kuwayama protocol. Group 2 blastocysts were cryopreserved with the Global Fast Freeze Kit using open system on cryotop vit. device and thawed using Global fast thaw kit. Blastocysts were assessed immediately for survival, subsequently cultured for 6-8 h, assessed for survival and expansion, then transferred and the percentages of Positive hCG, clinical pregnancy, implantation, multiple pregnancy and abortion were recorded.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of Ob. & Gyn.

Study Record Dates

First Submitted

September 2, 2018

First Posted

September 7, 2018

Study Start

October 1, 2015

Primary Completion

October 1, 2017

Study Completion

June 15, 2018

Last Updated

September 7, 2018

Record last verified: 2018-09